Gliknik Research

Gliknik is expert in immune modulation. We have three primary research platforms, each of which holds the promise of producing multiple innovative products:

The Immunomodulator Platform involves "off-the-shelf" peptide drugs that increase CD4, CD8, and antibody immune responses against cancer.
The Stradomer^TM Platform produces pure, recombinant drugs designed to mimic the eficacy of pooled human Intravenous Immunoglobulin.
The Stradobody^TM Platform produces compounds that are similar to moncolonal antibodies but designed to have increased tumor cell killing.